s6y
Company name or ticker
Search
Cullinan Therapeutics, Inc.
4
Fenton Mary Kay: Statement of changes in beneficial ownership of securities
Filed
Thursday, July 2, 2026
Period
Jun 30, 2026
Accession number
0001193125-26-294863
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header